Supplemental Figure 1 from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Authors:
  • SDSteven G. DuBois
    Steven G. DuBois
  • YMYael P. Mosse
    Yael P. Mosse
  • EFElizabeth Fox
    Elizabeth Fox
  • RKRachel A. Kudgus
    Rachel A. Kudgus
  • JRJoel M. Reid
    Joel M. Reid
  • RMRenee McGovern
    Renee McGovern
  • RBRochelle Bagatell
    Rochelle Bagatell
  • CTClare J. Twist
    Clare J. Twist
  • KGKelly Goldsmith
    Kelly Goldsmith
  • MGM. Meaghan Granger
    M. Meaghan Granger

Abstract
No abstract available